Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics
| Image |  |
|---|---|
| Description | scientific article published on 30 May 2017 |
| Author/s |
author: Robert M Sharkey Linda T Vahdat |
| Publication date | May 30, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |